Vimarsana
Biggest News Aggregation in the World

Page 2 - Adaptive Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adaptive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adaptive Research Today - Breaking & Trending Today

Global Coalition for Adaptive Research in Collaboration with Cure Brain Cancer Foundation Announce the Opening of Glioblastoma Clinical Trial in Australia - Vimarsana News

Global Coalition for Adaptive Research in Collaboration with Cure Brain Cancer Foundation Announce the Opening of Glioblastoma Clinical Trial in Australia

GBM AGILE Adaptive Platform Trial Recruiting in Australia

VAL-083 Fails to Outperform SOC in Glioblastoma - Vimarsana News

VAL-083 Fails to Outperform SOC in Glioblastoma

VAL-083 did not improve efficacy compared with standard-of-care approaches in patients with glioblastoma.

Global Platform Study Presents Results to Guide Care of Severely Ill Patients With COVID-19 Using Routinely Available Drugs – Simvastatin and Vitamin C - Vimarsana News

Global Platform Study Presents Results to Guide Care of Severely Ill Patients With COVID-19 Using Routinely Available Drugs – Simvastatin and Vitamin C

LARKSPUR, Calif. & PITTSBURGH--(BUSINESS WIRE)--Oct 25, 2023--

Statin Could Fight Severe COVID, Vitamin C Doesn't Help - Vimarsana News

Statin Could Fight Severe COVID, Vitamin C Doesn't Help

Simvastatin, a widely available and inexpensive drug that is included on the WHO list of essential medicines, was shown to have a high probability (96%) of improving outcomes (a combination of survival and length of time patients need support in an intensive care unit) when started as a treatment for critically ill patients with COVID-19, and a 92% chance of improving survival at 3 months.

Intravenous Vitamin C for Patients Hospitalized With COVID-19 - Vimarsana News

Intravenous Vitamin C for Patients Hospitalized With COVID-19

Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critica